This time it’s different, right? Maybe, but there are bubbly warning signs Outlook Did anyone make Dow 30,000 hats?
As winter sets in, Covid-19 and economic uncertainty loom Outlook Financial Freedom: Sizing up a turbulent fourth quarter
As companies have changed, so has their economic value Strategies How accounting can distort valuations
An AstraZeneca-backed vaccine heads toward approval Outlook Why markets are taking vaccine news in stride
Companies are finding new ways to monetize data Strategies Sizing up the value of data in a digital world
The luxury EV maker joins the ranks of the S&P 500 Strategies Careful what you wish for: Tesla edition
The global economy is very debt-laden with implications for investors Strategies Why we prefer quality for the long term
Green goods and services are a $4 trillion business Outlook The US green economy is a bipartisan growth story
It’s a game-changer in the global fight against the virus Strategies What the Moderna vaccine means for investors
A global pandemic has made video conferencing the norm Strategies How Zoom zoomed into the Russell 100
Fighting Covid-19 and fresh stimulus will be early priorities Outlook Strategies State Street: Biden wins the White House
A divided government is the ultimate best case for the equity markets Outlook Strategies Realizing the best election outcome for the markets
